D118 Unit 6 Study Guide

Discuss the Treatment for a Patient With Alzheimer’s Disease Who Is Experiencing Depression

Depression frequently co-occurs with Alzheimer’s disease, posing significant challenges. It can worsen cognitive deficits, increase functional impairment, and elevate the burden on caregivers. Treatment decisions must carefully balance efficacy with the increased vulnerability of elderly patients to side effects and drug interactions.

What is the preferred medication for treating depression in Alzheimer’s disease?

Selective Serotonin Reuptake Inhibitors (SSRIs) are generally considered the first-line pharmacologic treatment for depression in patients with Alzheimer’s disease. Their popularity is due to a favorable safety profile and minimal interactions with other medications commonly prescribed in this population. Among SSRIs, sertraline and citalopram are frequently used; both have demonstrated benefits in alleviating mood disturbances, anxiety, and emotional lability associated with dementia.

What nonpharmacologic strategies complement medication treatment?

In addition to medications, nonpharmacologic interventions are crucial for optimal management. These include establishing consistent daily routines to reduce confusion, educating caregivers to improve patient support, engaging patients in cognitive stimulation activities, and providing psychosocial support. If depression proves resistant to treatment, collaboration with psychiatric or geriatric mental health specialists is recommended.

---

What Is the Treatment for Guillain-Barré Syndrome?

Guillain-Barré Syndrome (GBS) is an acute autoimmune condition that causes rapid-onset muscle weakness, sometimes progressing to respiratory failure. Immediate treatment is critical to prevent severe complications.

The cornerstone of therapy is intravenous immunoglobulin (IVIG), which neutralizes harmful antibodies targeting peripheral nerves. Plasma exchange (plasmapheresis) offers an effective alternative, especially when IVIG is contraindicated or unavailable.

What supportive care is essential in GBS?

Supportive care is vital and includes vigilant respiratory monitoring to detect impending failure, preventive measures against complications like deep vein thrombosis, and initiating physical rehabilitation to promote recovery and restore function.

---

What Is Ankylosing Spondylitis and How Does It Relate to Seronegative Spondyloarthropathies?

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. It is classified under seronegative spondyloarthropathies—a group of disorders sharing genetic markers, such as HLA-B27, and lacking rheumatoid factor positivity.

This group also includes reactive arthritis, psoriatic arthritis, enteropathic arthritis (linked with inflammatory bowel disease), and undifferentiated spondyloarthritis. Early diagnosis and treatment are essential to prevent irreversible spinal fusion and preserve mobility.

---

What Are the Common Laboratory Findings Associated With Paget Disease of Bone?

Paget disease involves abnormal bone remodeling, resulting in structurally weak and deformed bones. Laboratory tests assist in diagnosis and monitoring.

Laboratory Test	Typical Finding	Clinical Significance
Alkaline phosphatase (ALP)	Elevated	Indicates increased bone turnover
Serum calcium	Usually normal	Elevated levels seen only with immobilization
Phosphorus	Normal	Helps rule out other bone disorders

An elevated serum ALP is the hallmark laboratory abnormality, reflecting increased osteoblastic activity. Additional tests such as bone-specific ALP and urinary hydroxyproline may provide further diagnostic insight.

---

Discuss the Diagnosis, Treatment, and Referral for a Patient With Infectious Arthritis

Infectious arthritis is an urgent condition that can lead to rapid joint destruction without timely intervention. It typically presents with acute joint pain, swelling, redness, fever, and limited movement. The knee is the most commonly involved joint.

Diagnosis involves a thorough clinical evaluation followed by joint aspiration. Analysis of synovial fluid (including Gram stain, culture, and cell count) is the gold standard for confirming infection. Imaging, such as X-rays or MRI, helps assess joint damage.

Treatment requires prompt administration of targeted antibiotics based on culture results and aggressive joint drainage through needle aspiration, arthroscopy, or surgery when necessary. Referral to orthopedic or infectious disease specialists is often warranted.

---

What Are the Common Manifestations of Osteoarthritis and What Is the Treatment Plan?

Osteoarthritis (OA) is a degenerative joint condition characterized by progressive cartilage deterioration. Symptoms typically include gradual joint pain and stiffness, worsened by both overuse and prolonged inactivity.

Clinical signs include crepitus (a grinding sensation), limited range of motion, joint swelling, and bony deformities. Weight-bearing joints like knees and hips are frequently affected.

Treatment focuses on symptom relief and maintaining function. Acetaminophen is recommended for mild pain, while nonsteroidal anti-inflammatory drugs (NSAIDs) are reserved for moderate discomfort. Intra-articular injections of hyaluronic acid may help mild to moderate cases. Lifestyle modifications, including weight management and physical therapy, are critical components.

---

What Medications and Dosages Are Appropriate in Treating Osteoporosis?

The pharmacologic goal in osteoporosis is fracture risk reduction through improved bone density. Oral bisphosphonates remain the primary treatment, requiring specific administration guidelines: taken on an empty stomach with plain water, followed by 30 minutes of upright posture to ensure absorption and reduce esophageal irritation. For example, ibandronate necessitates a 60-minute waiting period before eating.

Raloxifene, a selective estrogen receptor modulator (SERM), is used for preventing and treating postmenopausal osteoporosis at a daily dose of 60 mg.

---

Differentiate the Types of Dementia

Dementia encompasses disorders marked by progressive cognitive decline. The most common forms include Alzheimer’s disease and vascular dementia.

Type of Dementia	Pathophysiology	Key Features
Alzheimer’s disease	Amyloid plaques and neurofibrillary tangles	Gradual memory loss, cortical atrophy
Vascular dementia	Cerebral ischemia and infarcts	Stepwise cognitive decline, focal neurological deficits
Lewy body dementia	Lewy body protein deposits	Visual hallucinations, fluctuating cognition

---

Discuss the Treatment for Gout

Gout is an inflammatory arthritis caused by monosodium urate crystal deposition. Diagnosis is confirmed through synovial fluid microscopy, which identifies intracellular urate crystals.

Acute gout attacks are treated primarily with NSAIDs or oral corticosteroids. Corticosteroids are preferred in patients with renal impairment, anticoagulation, or liver disease. Early initiation of anti-inflammatory therapy within 24 to 48 hours is critical for symptom relief.

---

What Are the Common Manifestations of Rheumatoid Arthritis and the Treatment Plan?

Rheumatoid arthritis (RA) is a systemic autoimmune disorder characterized by symmetrical inflammation of multiple joints. Patients often experience prolonged morning stiffness exceeding one hour, fatigue, and weight loss.

Initial involvement commonly affects small joints of the hands and feet. Early and aggressive treatment with disease-modifying antirheumatic drugs (DMARDs), sometimes combined with biologic agents, NSAIDs, and glucocorticoids, is vital to control inflammation and prevent joint destruction.

---

What Medication Is Appropriate for Dyskinesia in an Alzheimer’s Patient?

In patients with Alzheimer’s disease who develop tardive dyskinesia, anticholinergic medications like benztropine are contraindicated because they can worsen cognitive function. The recommended approach includes discontinuing the causative medication, switching to atypical antipsychotics with lower dyskinesia risk, and involving psychiatric specialists for persistent symptoms.

---

What Medications Are Considered for Insomnia in a Patient With Fibromyalgia?

Sleep problems are common in fibromyalgia. Medications such as trazodone and zolpidem can assist with sleep initiation and maintenance, though they do not substantially improve the restorative aspects of sleep, like slow-wave sleep. Emphasizing nonpharmacologic sleep hygiene remains a cornerstone of management.

---

Define Migraine and Describe Its Signs and Symptoms

Migraine is a chronic neurovascular disorder characterized by episodic headaches, which may occur with or without an aura. The more common form, migraine without aura, features unilateral, pulsating pain lasting 4 to 72 hours, often accompanied by nausea, photophobia (sensitivity to light), and phonophobia (sensitivity to sound).

Migraine with aura includes transient neurological symptoms, such as visual or sensory disturbances, preceding the headache. Prodromal symptoms like fatigue, irritability, and food cravings may occur days before the attack.

---

What Are the Common Manifestations of Meningitis, How Is It Diagnosed, and What Is the Treatment Plan?

Acute bacterial meningitis often presents with fever, headache, and neck stiffness. However, older adults may exhibit atypical signs, including confusion or altered mental status.

Diagnosis requires rapid laboratory assessment, including blood cultures and lumbar puncture for cerebrospinal fluid analysis. Empiric antimicrobial treatment should commence immediately, often including vancomycin to cover resistant organisms.

---

References

American College of Rheumatology. (2020). Guidelines for the management of rheumatoid arthritis. https://www.rheumatology.org

Harrison, T. R., & Fauci, A. S. (2022). Harrison’s principles of internal medicine (21st ed.). McGraw-Hill Education.

National Institute on Aging. (2023). Alzheimer’s disease and related dementias. https://www.nia.nih.gov

UpToDate. (2024). Clinical manifestations and treatment of osteoarthritis. Wolters Kluwer.

World Health Organization. (2022). Neurological disorders: Public health challenges. https://www.who.int